Hans Henrik Chrois Christensen

Hans Henrik Chrois Christensen has a diverse work experience spanning over several decades. Hans Henrik began their career in 1990 at Bech-Bruun as a Junior Associate and later became an Associate. During their tenure, the firm experienced significant growth, partly due to mergers, and expanded to approximately 140 employees.

In 1998, Hans Henrik moved to Danisco A/S, a world-leading manufacturer of food ingredients. As a Corporate Legal Counsel, they worked on various aspects of the business, including high value-added ingredients, sugar production, and corporate ventures.

In 2002, Hans Henrik joined Pharmexa A/S, a biotech company engaged in the development of immunotherapy products and vaccines. Hans Henrik served as the Director of Legal Affairs and later became the Senior Vice President of Legal & Commercial Affairs. During their time at Pharmexa, the company was listed on NASDAQ Copenhagen and had subsidiaries in California.

From 2007 to 2017, Hans Henrik worked at Exiqon A/S, which operated in the life sciences and diagnostics sectors. As the CFO, they played a crucial role in the company's public listing on NASDAQ Copenhagen, financing rounds, and the acquisition of Oncotech Inc.

In 2017, they joined Samplix ApS, a life science start-up, as the CFO. Hans Henrik was responsible for overseeing finance, legal, IT, HR, and general administration. Under their leadership, the company successfully launched its first product, Xdrop™, a system for droplet-based PCR-free enrichment of genomic regions.

Currently, Hans Henrik holds the position of CFO & COO at Imcheck Therapeutics. This clinical-stage biotech company develops antibodies targeting butyrophilins for the treatment of cancer, infectious, and autoimmune diseases. In their role, they manage various aspects of the company's operations, including fundraising, investor relations, deal engineering, finance, IPO readiness, legal, HR, IT, and facility management.

Hans Henrik Chrois Christensen holds a Master's degree in Law from the University of Copenhagen. The specific start and end years of their education are not provided.